Crinetics Pharmaceuticals...
36.99
1.37 (3.85%)
At close: Jan 15, 2025, 10:29 AM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 4.01M 4.74M 1.08M 71.00K 1.19M 2.43M 2.04M 589.00K
Cost of Revenue n/a 1.39M 1.26M 57.00M 1.11M 24.48M 9.23M 5.10M
Gross Profit 4.01M 3.35M -184.00K -56.93M 80.00K -22.05M -7.19M -4.51M
Operating Income -222.61M -167.88M -107.70M -74.95M -53.83M -28.71M -9.13M -6.04M
Interest Income 13.44M 4.32M 157.00K 991.00K 3.46M 1.75M 26.00K 37.00K
Pretax Income -214.53M -163.92M -107.64M -73.81M -50.42M -27.11M -9.16M -6.02M
Net Income -214.53M -159.95M -106.72M -72.86M -49.53M -27.11M -9.16M -6.02M
Selling & General & Admin 58.09M 42.39M 24.52M 18.03M 13.52M 6.66M 1.94M 1.53M
Research & Development 168.53M 130.22M 84.25M 57.00M 41.51M 24.48M 9.23M 5.10M
Other Expenses n/a 4.97M 61.00K -71.00K -1.19M 1.59M -48.00K -1K
Operating Expenses 226.62M 172.62M 108.78M 74.95M 53.83M 28.71M 9.13M 6.04M
Interest Expense n/a 4.32M n/a n/a n/a n/a 8.00K 11.00K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 226.62M 172.62M 108.78M 74.95M 53.83M 28.71M 9.13M 6.04M
Income Tax n/a -3.96M -922.00K -948.00K -887.00K 1.59M -40.00K 10.00K
Shares Outstanding (Basic) 58.07M 51.98M 38.44M 30.45M 24.18M 12.14M 13.88M 13.88M
Shares Outstanding (Diluted) 58.07M 51.98M 38.44M 30.45M 24.18M 12.14M 13.88M 13.88M
EPS (Basic) -3.69 -3.08 -2.78 -2.39 -2.05 -2.23 -0.66 -0.43
EPS (Diluted) -3.69 -3.08 -2.78 -2.39 -2.05 -2.23 -0.66 -0.43
EBITDA -221.51M -166.90M -106.78M -72.59M -49.31M -28.24M -9.00M -5.95M
Depreciation & Amortization 1.10M 1.39M 1.26M 1.23M 1.11M 471.00K 128.00K 92.00K